1. Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens

   • Richard L. Dunbar
   • Harsh Goel

   Nonstatin Drugs (E. deGoma, Section Editor) Open access 15 February 2016 Article: 11

   

2. Cardiac Rehabilitation in Patients with Established Atherosclerotic Vascular Disease: New Directions in the Era of Value-Based Healthcare

   • Karen Aspry
   • Wen-Chih Wu
   • Elena Salmoirago-Blotcher

   Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 23 January 2016 Article: 10

3. Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions

   • J. Adam Leigh
   • Manrique Alvarez
   • Carlos J. Rodriguez

   Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 20 January 2016 Article: 9

   

4. The Role of Ezetimibe in the Treatment of Cardiovascular Disease

   • Anandita Agarwala
   • Zaid Kajani
   • Salim S. Virani

   Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 20 January 2016 Article: 8

   

5. Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists

   • Ashish Sarraju
   • Sun H. Kim
   • Joshua W. Knowles

   Nonstatin Drugs (E. deGoma, Section Editor) 19 January 2016 Article: 7

   

6. Women Versus Men: Is There Equal Benefit and Safety from Statins?

   • Roda Plakogiannis
   • Sally A. Arif

   Statin Drugs (B. Wiggins, Section Editor) 18 January 2016 Article: 6